Bellwether is a UW Genomics start-up developing new tools to enable early detection of cancer and other diseases through "Liquid Biopsy," The company's technology can be used to trace tell-tale DNA fragments circulating within a patient's blood to the tissues/organs of origin.
Click here to access the company's website.
UW Spinout Bellwether Bio Raises $2.8M in Seed Financing
February 10, 2017
Bellwether Bio, a liquid biopsy startup that recently spun out of the University of Washington, has raised almost $2.8 million in seed financing. ... [Click for more] ...